Terns Pharmaceuticals (TERN) Q2 2025 Earnings

May 8Confirmed
Q3 2024
Q4 2024
Q1 2025
Q2 2025
-0.34
-0.31
-0.27
-0.24

Details

Expected EPS
-0.293932
Actual EPS
-0.26
Surprise EPS
0.03
Surprise Percent
+11.54%

Description

⁨Terns Pharmaceuticals⁩ (⁦TERN⁩) has reported earnings of ⁦-0.26⁩ per share for ⁦Q2 2025⁩.

0 Comments

Share your thoughts